Molecular detection of tumor cells at diagnosis invading the bone marrow and peripheral blood of patients with aggressive or indolent lymphomas.
We studied tumor cell invasions of bone marrow and peripheral blood in patients with various types of advanced non-Hodgkin's lymphoma by amplifying complementarity determining region III using the polymerase chain reaction (PCR) method and developing patient-specific probes. After molecular engineering, we could detect tumor cells in bone marrow from seven of 11 cases and in peripheral blood from six of 11 cases, despite negative results in four cases studied morphologically. Indolent cases were more likely to yield positive results than aggressive cases. The reason may be different biological behaviors among the histological types.
Yokohama
A
A
Third Department of Internal Medicine, Gunma University, School of Medicine, 3-39-15 Showa-cho, Maebashi, 371-8511, Gunma, Japan. ayoko@showa.gunma-u.ac.jp
Karasawa
M
M
Sakai
H
H
Okamoto
K
K
Maehara
T
T
Tsukamoto
N
N
Tamura
J
J
Naruse
T
T
Sawamura
M
M
Shimano
S
S
D019046:Bone Marrow Neoplasms / Q000235:genetics / Q000556:secondary*; D022801:Complementarity Determining Regions / Q000235:genetics*; D004273:DNA, Neoplasm / Q000032:analysis*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000473:pathology; D008113:Liver Neoplasms / Q000235:genetics / Q000556:secondary; D008223:Lymphoma / Q000145:classification / Q000175:diagnosis / Q000235:genetics / Q000473:pathology*; D009361:Neoplasm Invasiveness; D009693:Nucleic Acid Hybridization / Q000379:methods; D016133:Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D013160:Splenic Neoplasms / Q000235:genetics / Q000556:secondary
D022801:Complementarity Determining Regions; D004273:DNA, Neoplasm